Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection and Identification of Preeclampsia Via Volatile Biomarkers

NCT01291342 is registered in ClinicalTrials.gov with The Nazareth Hospital, Israel as lead sponsor.

NCT NCT01291342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01291342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection and Identification of Preeclampsia Via Volatile Biomarkers
Lead sponsor
The Nazareth Hospital, Israel
Phase
Observational
Overall status
Completed
Start date
September 30, 2011
Completion date
September 30, 2012
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy; death of fetus, early pregnancy, uremia in pregnancy without hypertension